Tocilizumab Does Not Improve Outcomes in Severe COVID - 19

Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Infections, Nursing, Pharmacy, Pulmonology, Critical Care, Journal, Source Type: news